|
|
Glaucoma: A Silent Blinding Disease
Course of the Month - November 2023
|
|
Facebook
LinkedIn
E-Mail
|
(907)
|
Course of the Month
November 2023
Each month, the American Association of Nurse Practitioners® (AANP) will offer a continuing education (CE) activity presented by experts from AANP Communities. For the first month that it is offered, the activity will be FREE and only available to AANP members. After the initial month has passed, the activity will become available to both AANP members and non-members for a fee (AANP members will pay a significantly discounted price). The featured activity will rotate each month, so be sure to complete the activity and earn your CE credit before the month ends to benefit from free access!
Are you interested in this activity but not yet an AANP member? Becoming an AANP member can help you save on the purchase of this course and others — and it will provide you a full year of access to exclusive member benefits. Learn more about AANP membership and consider becoming a member today!
Promotional
Content Expires: | November 30, 2023 (11:55 p.m. CT) | | Content Expires: | October 31, 2024 (11:55 p.m. CT)
CE for this activity will not be available after this date. |
 | This activity includes closed captioning. |
This activity is free for AANP members from 11/1/2023 - 11/3/2023 |
Overview  Glaucoma is the leading cause of irreversible blindness worldwide following cataracts and the most common cause of blindness among all eye conditions. The glaucomas are a group of progressive optic neuropathies characterized by degeneration of retinal ganglion cells (RGC) and resulting changes in the optic nerve head including progressive thinning of the neuroretinal rim and retinal nerve fiber layer (RNFL). Pathogenesis of glaucoma is not fully understood, but the level of intraocular pressure is related to ganglion cell death glaucoma patients are typically asymptomatic, even with more advanced disease. Glaucoma evaluation includes careful optic nerve examination to detect glaucomatous optic nerve damage intra-ocular pressure diurnal curve testing, gonioscopy to evaluate angle, visual field test and optic nerve imaging. The goals of glaucoma treatment include slowing disease progress and preservation of quality of life and reduction of intra-ocular pressure.
Objectives
- Explain the impact of glaucoma disease as a blinding disease.
- Review the types of glaucoma disease.
- Explain the evaluation techniques of the optic nerve to detect glaucoma.
- Discuss the medical and surgical treatment options for glaucoma.
Speakers
Tulay Cakiner-Egilmez, ANP, PhD, CRNO, COMT
Disclosure This program was planned in accordance with AANP CE Standards and Policies.
Speaker Disclosures:
- The speaker has no conflict of interest relevant to this topic.
- This lecture will provide only a quick review and will not cover every aspect of glaucoma.
- The opinions expressed are those of the author from her personal experience those of the Department of Veterans Affairs and are informational only, not necessarily those of the Department of Veterans Affairs.
- The speaker will not talk about pediatric glaucomas.
All relevant relationships have been mitigated.DisclaimerIndividuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program. CE Credit Instructions
- Read this activity description, including objectives and disclosures.
- Complete all educational content:
- Video Presentations: Click the Play button to watch the activity video lecture. To get full credit for the learning activity portion, you must watch all of the video content.
- Click on the Additional Resources button to review all additional materials provided (handouts and any other downloadable resources).
- After completing all educational content, go to the Next Steps button:
- Submit the activity evaluation to receive full AANP CE/Rx credit.
- Click on the Get Certificate button.
- A copy of your certificate of completion will display on the screen for you to print or save. A copy of the certificate will also be emailed to you.
- A copy of the certificate will be automatically added to your AANP CE Tracker.
Additional Information
For questions or more information concerning this CE Center activity, contact AANP CE Center Support at cecenter@aanp.org.
1.05 Contact Hour(s) of CE,
0.1 of which may be applied towards Pharmacology
|
|
|
|
Adding Registration, Please wait...
